GLP-1 Insurance Checker: Does Your Plan Cover Wegovy, Zepbound or Ozempic?
It depends on your plan and your diagnosis. Plans generally cover GLP-1s for diabetes, but only 18% of large employers covered them for weight loss in 2026.1
The check happens during Zealthy signup. Active membership required: $39 in the first month, $135 a month after.
What the check includes
- Online review by a licensed provider
- Prior authorization for brand-name medication, submitted by our insurance coordination team
- When your plan covers the medication, a copay that can be as low as $25 a month
Your plan decides coverage. Approval is never guaranteed.
How the Zealthy coverage check works
The check is part of signup, not a form on this page.
-
Answer health questions
Complete the online intake. No live appointment is needed.
-
A provider reviews
A licensed provider reviews your answers and decides if a GLP-1 is right for you.
-
We request approval
For brand-name medication, our insurance coordination team submits the prior authorization to your plan.
-
Your plan answers
If it covers the medication, the prescription goes to your own pharmacy. If not, your provider may discuss other options.
Does insurance cover GLP-1 medication?
Often for type 2 diabetes, far less often for weight loss.1 The FDA approved Ozempic® for type 2 diabetes, not weight loss, and approved Wegovy® and Zepbound® for weight management.2,3,4 So a plan can cover a GLP-1 for one diagnosis and refuse it for another.
| Plan type | For type 2 diabetes | For weight management |
|---|---|---|
| Employer or commercial | Generally covered1 | Covered by 18% of employers with 200 or more workers in 20261 |
| Marketplace (ACA) | Depends on the plan’s drug list5 | |
| Medicare Part D | Part D plans may cover it6 | Through the temporary Medicare GLP-1 Bridge: $50 a month if eligible6 |
| Medicaid | Must be covered7 | Optional for states. 13 state programs covered it under fee-for-service as of January 20267 |
| TRICARE | Covered with prior authorization8 | Wegovy and Zepbound covered with a network provider’s prescription and prior authorization, except under TRICARE For Life8 |
What is a GLP-1 prior authorization?
A prior authorization is approval that you or your prescriber must get from the plan before it covers certain drugs.9
Criteria vary by plan. Two themes recur in public sources: the BMI range these drugs are meant for (30 or greater, or 27 or greater with a weight-related health problem)10 and a lifestyle program, required by 40% of large employers that cover GLP-1s for weight loss.1 Some plans also use step therapy, where you first try a less expensive drug.9
What if insurance denies your GLP-1?
You can appeal. Under federal appeal rules, the insurer must explain a prior authorization denial in writing within 15 days. You have 180 days to file an internal appeal, then four months after a final denial to request an external review, whose decision the insurer must accept.11,12 Medicare, Medicaid and TRICARE have their own processes.
What do GLP-1s cost without insurance coverage?
As of November 2026, the manufacturers’ self-pay prices, which sit outside insurance, are:
- Wegovy pen: $349 a month for doses up to 2.4 mg. New patients pay $199 a fill for the first two fills of 0.25 mg or 0.5 mg through December 31, 2026.13
- Zepbound KwikPen or vial: $299 for 2.5 mg, $399 for 5 mg, and $449 for higher doses when refilled within 45 days.14
- Ozempic pen: $349 a month, or $499 for 2 mg, with the same $199 new-patient offer.15
If your plan will not cover a brand-name medication, your provider may discuss other options, including compounded semaglutide ($199 a month, or from $106 a month with a 3-month supply) and compounded tirzepatide ($329 a month, or from $216 a month with a 3-month supply). Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality.16
Important safety information
Wegovy, Zepbound and Ozempic have a boxed warning for thyroid C-cell tumors. Do not use them with a personal or family history of medullary thyroid carcinoma, with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or after a serious allergic reaction to them. Serious risks include pancreatitis, gallbladder problems, low blood sugar, kidney injury and severe stomach problems. Nausea, diarrhea, vomiting and constipation are common.2,3,4
Full details: Wegovy, Zepbound, Ozempic, semaglutide, tirzepatide.
GLP-1 insurance FAQs
Does insurance cover Wegovy or Zepbound for weight loss?
Sometimes. In 2026, 18% of employers with 200 or more workers covered GLP-1s for weight loss in their largest plan.1 Medicaid coverage for obesity is optional for states.7 A plan that covers Wegovy or Zepbound may still require a prior authorization.
Does my insurance cover Ozempic for weight loss?
It depends on your diagnosis. Health plans have generally covered medications like Ozempic for people with diabetes, and its FDA approval is for type 2 diabetes, not weight loss.1,2 Weight loss alone is an off-label use, so check your plan’s drug list.
Does Medicare cover GLP-1s for weight loss?
Yes, for eligible people, through the Medicare GLP-1 Bridge. The temporary program runs from July 1, 2026 to December 31, 2027 and covers Wegovy, the Zepbound KwikPen and Foundayo® for $50 a month.6,17 You need a BMI of 35 or higher, or from 27 with a qualifying condition such as prediabetes.6
How much does the Zealthy coverage check cost?
It is included in Zealthy membership: $39 in the first month, $135 a month after that. Membership also covers provider review, unlimited secure messaging and a weight loss coach. Medication is not included, and brand-name prescriptions go to your own pharmacy.
Can I use a GLP-1 savings card with Medicare or Medicaid?
No. Savings cards for Wegovy, Zepbound and Ozempic can cut a commercially covered fill to as little as $25, but they exclude people with Medicare, Medicaid, TRICARE, VA or other government drug coverage.13,14,15 People with Medicare Part D or Medicaid can still use Novo Nordisk’s Ozempic self-pay options.15
Are there options if my insurance will not cover a GLP-1?
Yes. You can appeal, compare self-pay prices, or ask your Zealthy provider about other options, which may include compounded semaglutide or compounded tirzepatide. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality.16
Sources
- KFF. 2026 Employer Health Benefits Survey. https://www.kff.org/health-costs/2026-employer-health-benefits-survey/
- Ozempic Prescribing Information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- Wegovy Prescribing Information. Revised 06/2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Zepbound Prescribing Information. Revised 08/2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- HealthCare.gov. Getting prescription medications. https://www.healthcare.gov/using-marketplace-coverage/prescription-medications/
- Medicare.gov. Weight loss drugs. https://www.medicare.gov/glp1bridge
- KFF. Medicaid Coverage of and Spending on GLP-1s. https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/
- TRICARE. Does TRICARE cover Wegovy, Ozempic, and Mounjaro? August 2026. https://www.tricare.mil/FAQs/Pharmacy/PharmProg_Wegovy
- Medicare.gov. Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-plans-cover/plan-rules
- NIDDK. Prescription Medications to Treat Overweight and Obesity. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
- HealthCare.gov. Internal appeals. https://www.healthcare.gov/appeal-insurance-company-decision/internal-appeals/
- HealthCare.gov. External review. https://www.healthcare.gov/appeal-insurance-company-decision/external-review/
- Novo Nordisk. Wegovy savings offer terms. https://www.wegovyterms.com
- Eli Lilly. Zepbound savings. https://zepbound.lilly.com/savings
- Novo Nordisk. Ozempic cost and coverage. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
- FDA. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- CMS. Medicare GLP-1 Bridge. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
Check your GLP-1 coverage
Answer a few health questions online. A licensed provider reviews them, and membership starts at $39 for the first month.

Your plan decides. We send the request.
A licensed provider reviews your history, and our insurance coordination team submits the prior authorization.
The medical information on this page is reviewed by the Zealthy care team against FDA prescribing information and published clinical trials. It is general education, not personal medical advice.
What Zealthy members say
One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
I started semaglutide at the recommendation of my Zealthy provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and Zealthy was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Since I started, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Individual results may vary. These are the experiences of Zealthy members and are not a guarantee of any outcome. Medication is prescribed only when a licensed provider finds it appropriate.
GLP-1 medications Zealthy providers can prescribe
Brand-name or compounded, a licensed provider decides what fits your health history. Our insurance team handles the prior authorization paperwork for brand-name medication.
Zepbound®
Tirzepatide, FDA-approved for weight management and for sleep apnea in adults with obesity.
Zepbound cost, savings card and side effects →Wegovy®
Semaglutide, FDA-approved for weight management, as a weekly injection or a daily pill.
Wegovy pill, cost and side effects →Mounjaro®
Tirzepatide, FDA-approved for type 2 diabetes. The same ingredient as Zepbound.
Mounjaro doses and savings card →Ozempic®
Semaglutide, FDA-approved for type 2 diabetes. Weight loss is an off-label use.
Ozempic side effects and cost →Compounded semaglutide
$199 a month, or from $106 a month on a 3-month supply, shipping included. Not FDA-approved.
Semaglutide cost and dosing →Compounded tirzepatide
$329 a month, or from $216 a month on a 3-month supply, shipping included. Not FDA-approved.
Tirzepatide dosage and cost →Compounded medications are prepared by a partner pharmacy for an individual prescription. They are not FDA-approved, which means the FDA has not reviewed them for safety, effectiveness or quality. Zealthy membership ($39 for the first month, then $135 a month) is billed separately from medication. A prescription is written only if a licensed provider finds it appropriate.